Professor, Sechenov University, Moscow
Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Director, Center for Personalized Medicine, Sechenov University and Chair,Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born on 11 Jan 1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, National Institute of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Institute in Moscow; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA; Chair, Department for Clinical Immunology, Moscow Clinical Research Institute; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels.
Robin C. N. Williamson
Professor RCN Williamson MA MB MChir MD (Cantab), FRCS (Eng), FRCS (Ed) Hon FRCS (Thailand), Hon DMedSci (Mahidol), United Kingdom, London
Robin Williamson is a retired gastrointestinal surgeon from the United Kingdom with a particular interest in the pancreas. He qualified from Cambridge University and St Bartholomew’s Hospital, London. After surgical training in London, Reading and Bristol he spent one year at the Massachusetts General Hospital and Harvard University, Boston, USA. He wrote an MChir thesis on intestinal adaptation and an MD thesis on intestinal carcinogenesis. He was appointed Professor of Surgery in Bristol at the age of 36 years (1979) and then, in 1987, moved to become Professor and Director of Surgery at the Royal Postgraduate Medical School (now a part of Imperial College) and the Hammersmith Hospital, London. He was Editor of the British Journal of Surgery between 1991-1996, President of the International Hepato-Pancreato-Biliary Association in 1996-1998, President of the European Society of Surgery in 1998, President of the Association of Surgeons of Great Britain and Ireland in 1998-1999 and inaugural President of the Association of Upper Gastrointestinal Surgeons, UK (1996-98). Retiring from NHS clinical practice in 2009, he acted as Deanery Tutor in Surgery and Foundation Training Programme Director at Imperial College for the next four years; he still teaches anatomy at Charing Cross Hospital, London. He started a parallel career at the Royal Society of Medicine in London on 2001, serving successively as Associate Dean, Dean and then 102nd President (2008-2010). In 2010 he became Medical Trustee at the London Clinic, London’s largest independent hospital, and he was Chairman between 2012-2016. He was on the Joint Advisory Board of Weill-Cornell Medical College in Qatar (2013-2016). He recently co-edited the second edition of a major surgical textbook: Surgery: Core Principles and Practice (2017).
Milad S. Bitar
Professor , Kuwait University, Kuwait
Professor Bitar earned a B.S at Oklahoma State University and an M.Sc. in biochemistry and a Ph.D. in Pharmacology at University of Maryland. He performed his postdoctoral at the National Institutes of Health in Bethesda, Maryland. Currently he is a Professor of Pharmacology at Kuwait University, School of Medicine and a Consultant at the Dasman Diabetes Research Center. In addition he is a Fellow in American Collage of Clinical Pharmacology. Dr. Bitar has long experience in the field of oxygen radical biology, with special emphasis regarding the role of Reactive Oxygen Species (ROS) in signaling derangement leading to tumor growth and various diabetic complications including sarcopenia, delayed wound healing and impaired angiogenesis. Most experiments in these areas are conducted on genes, cells and animal models in addition to clinical research in patients with non-healing diabetic ulcers. He has published more than 100 papers in reputed journals and also has a number of patents for new drugs to treat impaired angiogenesis and delayed wound healing.
Associate Professor of Surgery, Emory University School of Medicine
Dr. Pickens received his medical degree from the University of Alabama, Birmingham, where he also completed his general surgery residency. He did his cardiothoracic surgery residency at the University of Michigan in Ann Arbor, completed a minimally invasive chest surgery fellowship at Cedars-Sinai Hospital in Los Angeles, and did an esophageal surgery fellowship at U-M. From 2005 to 2008, Dr. Pickens was an assistant professor at U-M, where he initiated and directed the Minimally Invasive Thoracic Surgery Program.
After arriving at Emory, Dr. Pickens was appointed to direct Emory Healthcare's minimally invasive thoracic surgery and thoracic oncology services, and implemented the MIS thoracic surgery program at Emory University Hospital Midtown. His specialties include lung transplantation, robotic thoracic surgery, and the minimally invasive removal of early stage lung cancers and esophageal cancers using such procedures as Video Assisted Thorascopic Surgery (VATS), a type of thoracic surgery performed using a special video camera that is introduced into the patient's chest via small incisions.
Clinical and translational lung cancer research
Minimally invasive surgical technology
Associate Professor, Emory University School of Medicine
Dr.Sharma specializes in thyroid and parathyroid surgery, adrenal gland surgery, and pancreatic endocrine tumors. He routinely performs outpatient parathyroidectomies, outpatient thyroidectomies, and adrenalectomies using minimally invasive methods and has published various journal articles on these techniques.
Professor, Radboud University, Netherlands
Professor Merel Ritskes-Hoitinga is a professor of Evidence-Based Laboratory Animal Science at the Department for Health Evidence at the Radboud University Medical Center. Her field of expertise is preclinical work, with a special focus on the value of systematic reviews of preclinical animal and non animal studies for human medicine.
Luisa Maria Arvide Cambra
Professor, University of Almería, Spain
Professor Dr. Luisa Maria Arvide Cambra, Spanish is now Professor with Chair at the University of Almería (Spain).
Forty nine years of the teaching and researching experience. She is the Director of Research Group HUM113-Estudios Filológicos from Program of Research of Andalusian Government, where she has managed and directed several academic and scientific contracts and research projects, as well as a Member of European Scientific Institute (ESI) Team, Athens Institute for Education & Research (ATINER) in Greece, The Academic Genesis Platform (UAGP) in UK&Turkey and Experts of Academic Excellence Research Centre (EAERC) in Jordan; GI Social Sciences Forum (GISSF), in Malaysia; Akademica Nusa International Association of Social Sciences and Humanities, in UAE; Science Research Association (SCIREA); Academic Fora; Foundation for Social Sciences and Education Research (FSSER); etc.She is author of a many works on several aspects of the Arabic science and literature in the Middle Ages, as well as Arabic language and linguistics. She has also participated in different prestigious international scientific Conferences. She has visited a many universities and academic institutions of Europe, United States and Arab countries in order to teach and research. Among her works, we have the study and the translation to Spanish of some treatises of Kitab al-tasrif´s Al-Zahrawi, Ibn Qutayba´s texts, Maqamas of Al-Hariri, The Sicilian Questions of Ibn Sab´in, and the book on the plague by Ibn Khatima.
Medieval Arabic Science.Aging, Humanities. Arabic Philology